Search results

  1. E

    One-Year Follow-up of Young People with ME/CFS Following Infectious Mononucleosis by Epstein-Barr Virus, 2023 Scheibenbogen et al

    One-year follow-up of young people with ME/CFS following infectious mononucleosis by Epstein-Barr virus Background: Infectious mononucleosis after primary infection with Epstein-Barr virus (EBV-IM) has been linked to the development of myalgic encephalomyelitis/chronic fatigue-syndrome (ME/CFS)...
  2. E

    Review nature reviews cardiology: Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health care burden, Fedorowski et al, 2024

    In his defence Twitter can be a very aggressive medium, where harassment is a very close cousin to justified criticism. I suppose there might be better places to discuss such things than social media (email often seems more fruitful).
  3. E

    Vaccine Effectiveness Against Long COVID in Children: A Report from the RECOVER EHR Cohort, 2023, Hanieh Razzagh et al

    Now available as Prepublication Release in AAP Pediatrics as Vaccine Effectiveness Against Long COVID in Children.
  4. E

    A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue, 2024, Harandi

    Amantadine (Gocovri) is used in the treatment of Parkinson, albeit its mechanism of action is poorly understood, and is used as an antiviral in influenza caused by type A influenzavirus. It acts as a nicotinic antagonist, dopamine agonist, and noncompetitive NMDA antagonist. The basis for this...
  5. E

    A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue, 2024, Harandi

    A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue Abstract Many COVID-19 survivors experience lingering post-COVID-19 symptoms, notably chronic fatigue persisting for months after the acute phase. Despite its prevalence, limited research has explored...
  6. E

    Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation, 2022, Ahmed, Hanson et al.

    The study has now been published in Cell Reports Medicine as Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation.
  7. E

    Muscle abnormalities worsen after post-exertional malaise in long COVID, 2023/4, Wüst, van Vugt, Appelman et al

    I agree that social media is bad for discussing anything research related and shouldn't really be used for that. I was more so proprosing to contact him (or one of the patient representatives) via email.
  8. E

    Muscle abnormalities worsen after post-exertional malaise in long COVID, 2023/4, Wüst, van Vugt, Appelman et al

    I also suspect following the discussion might be somewhat confusion if one isn't used to S4ME, because the discussion is already 8 pages long. Indeed they are, to some extent, collaborating with Pretorius as well as Fluge/Mella (see also...
  9. E

    Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naÏve individuals with Long COVID, 2024, Iwasaki et al

    Of course the small sample size and lack of controls makes it impossible to say too much about these results. Maybe this can be followed-up by a larger and controlled study, but if that was worth it they probably would have gone for such a study straightaway. What I definitely learnt: I never...
  10. E

    News from the USA, United States of America

    This is absolutely horrendously bad epidemiological modelling for people who don't understand any basic mathematics. Apply this principle to any virus and humans would have been extinct centuries ago, but of course they aren't because this model is absolute crap (hard to even call it a model)...
  11. E

    Trial Report The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia, 2024, Català +

    This data includes vaccine effectiveness (LC rate among all people). Their data suggests that the vaccines had a tremendous impact at preventing a Covid-19 infection altogether (roughly 3.5 times better odds at not getting infected), at a larger rate than what I have seen in more rigorous...
  12. E

    Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naÏve individuals with Long COVID, 2024, Iwasaki et al

    Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naÏve individuals with Long COVID Abstract Background: Long COVID contributes to the global burden of disease. Proposed root cause hypotheses include the persistence of SARS-CoV-2 viral reservoir, autoimmunity, and...
  13. E

    Muscle abnormalities worsen after post-exertional malaise in long COVID, 2023/4, Wüst, van Vugt, Appelman et al

    You might enjoy this thread @Simon M where some users are expressing their understanding of the "PEM" nomenclature. My impression is still that we often know how PEM feels but that, that is something that hasn't sufficiently been understood or investigated (very similar to how the brain...
  14. E

    Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020, 2024, Gebhard et al.

    I'm not too sure there's any information on how the bland non-hospitalised data can be interpreted (I'm guessing there could be some other factors as well, maybe some questionnaires/methods nowadays viewed as standard were only ever standardised by testing them on males?) Another possible...
  15. E

    Dr Karl Morten - UK researcher based at Oxford University

    The problem with that is that this test is scientifically validated and FDA approved (which is a specified independent non-profit authority). It's scientifically validated that it measures antibodies, the problem is just that this measurement is essentially meaningless. There's sort of two...
  16. E

    Dr Karl Morten - UK researcher based at Oxford University

    I most definitely share this concern. Especially since things don’t seem to be improving. But I also don’t know how this could be easily addressed. Supposedly the founders of Celltrend believed that GPCR-aabs played a role in ME/CFS but couldn’t measure them and as such founded a company that...
  17. E

    Dr Karl Morten - UK researcher based at Oxford University

    I would say if the test, tests spitting on copper sulphate and it turns blue and all the test claims to do is exactly that it wouldn't be a fake test, just an inherently useless one and I certainly agree, that this test as well as the Celltrend test would show nothing but their own results. As...
  18. E

    Dr Karl Morten - UK researcher based at Oxford University

    I don't disagree that the test is meaningless (at least based on all currently available evidence). But philosophically that is different to something being a "fake test", at least the way I interpret it. A "fake test" in my eyes would be something that is somehow inaccurate or gives results...
Back
Top